PRX-167700

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NamePRX-167700
Drug Alias NamePRO VAP-1 inhPRX-167700PRX 167700H
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAmine oxidase, copper containing inhibitors
TargetsAmine oxidase, copper containing
Therapy Area/IndicationsOsteoarthritis, Knee
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesCambridge Biotechnology
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesProximagen LtdF. Hoffmann-La Roche Ltd
Active IndicationsN/A
Inactive IndicationsOsteoarthritis, Knee

Other Information

ATC CodeN/A
Related LinksN/A